Sinofn Health Sinofn Health

Custom SINOFN Health Supplement Innovation Factory & Factories

Global Leaders in Nutraceutical R&D, Clinical Nutrition & Intelligent Manufacturing

About SINOFN: The Science-Driven Engine

SINOFN Health Co., Ltd. represents the pinnacle of specialized nutraceutical manufacturing. Founded in 2012, backed by the rigor of the Chinese Academy of Sciences, we have evolved into a global powerhouse for supplement OEM/ODM services. We do not just manufacture products; we engineer bio-available health solutions. From our headquarters in Shanghai, we provide enterprise-grade contract manufacturing for brands seeking to enter the premium wellness space.

Our Philosophy: "Science-Driven OEM for Global Supplement Brands." We merge high-tech academic research with industrial-scale agility, ensuring that every batch of supplements meets the highest international quality standards (FSSC 22000, HACCP, ISO22000).

Global Health Supplement Industrial Status & Trends

The Paradigm Shift: From Generic to Personalized

The global nutraceutical industry is undergoing a "precision revolution." Modern consumers are moving away from broad-spectrum multivitamins towards targeted, efficacy-verified formulations. SINOFN is at the forefront of this shift, leveraging our R&D center in Tianjin to bridge the gap between clinical research and consumer retail products.

Technology Roadmap: Bio-Innovation

Our technology roadmap focuses on three pillars: Bioavailability Optimization, Controlled Release Systems, and Clean Label Formulation. By integrating scientific advancements—such as our work with Tremella Polysaccharides and NMN precursors—we empower our partners to market products that offer tangible, scientifically verifiable results.

Macro Solution: Bridging the Accessibility Gap

A key differentiator of SINOFN is our origin story rooted in PKU (Phenylketonuria) treatment. This "Purpose-Driven Profit" model defines our macro industry solution: applying the rigorous safety and efficacy standards required for medical foods (FSMP) to the wider consumer supplement market. When you choose SINOFN, you are choosing a partner that understands the stakes of metabolic health.

R&D Elite Team

Our R&D team is comprised of academic elites. Led by Dr. Tan Shengjie (Peking University Medical School) and supported by postdoctoral researchers from the Chinese Academy of Sciences, our team is not merely composed of formulators, but medical scientists.

  • Medical Innovation: Dr. Tan Shengjie oversees metabolic disorder formulations, ensuring our products are grounded in biological reality.
  • Bioactive Delivery: Dr. Zhang Ying specializes in bioactive compound delivery, critical for the effectiveness of high-end supplements like NMN and peptides.
  • Global Expertise: With Hans van Dijk (Netherlands) leading our industrialization engineering, we bridge eastern R&D capabilities with Western regulatory and quality expectations.
53000㎡Production Area
25+Patents Held
71+Trademarks
500M+Annual Capacity

Advanced Factory Infrastructure

Our manufacturing complex represents the "Industry 4.0" standard in nutraceuticals. With 10+ specialized production lines, we handle everything from softgels and gummies to complex powder blending and specialized medical liquid mixtures. Our "Full-Plant Integration" model—spanning from raw material procurement and blockchain-backed batch tracking to final automated packaging—ensures total transparency and quality control.

Expert FAQ: Understanding SINOFN

1. How does the partnership with the Chinese Academy of Sciences enhance product quality?

Our connection to CAS allows us to utilize the latest in biochemical research before it reaches the mass market. This ensures our formulations (like our Tremella polysaccharide range) are stable, bioactive, and scientifically superior to standard market alternatives.

2. Can SINOFN assist with regulatory compliance for global exports?

Yes. With our expertise in EU/US regulatory standards and our internal team’s background in medical food compliance, we guide partners through the complex landscape of global nutraceutical registration.

3. Is the manufacturing process scalable for startups?

Absolutely. While we are a massive facility (500M+ units annual capacity), our pilot-scale prototyping service is designed specifically to help startups and innovative brands launch without requiring prohibitive Minimum Order Quantities (MOQs).